Lemonade (LMND) delivered another quarter of top-line acceleration. Its third-quarter loss of $0.56 per share beat the -$0.60 consensus by 6.7%, and revenue of $336.1 million topped the $322.11 million estimate by 4.3%. Revenue grew 72.8% year over year, and management raised full-year revenue guidance for a third straight quarter. Yet the loss deepened, with per-share earnings down 9.8% from a year ago. Rising loss ratios in pet and Europe absorbed the benefit of the revenue raise, so the fourth-quarter adjusted EBITDA guide stayed at $5 million to $9 million rather than moving higher. That is the central tension: growth is improving, but the path from growth to profit is not getting any shorter.
The press release itself only pointed investors to the shareholder letter, so the substance came from the call. On the growth side, the evidence was strong. In-force premium reached $1.55 billion, up 34%, the 12th consecutive quarter of acceleration. Growth has stepped up from 31% in Q4 FY25 to 32% in Q1 and 32.5% in Q2. Customer additions of roughly 212,000 compared with about 166,000 in Q2. Premium per customer growth improved to 9% from 8%, and the annual dollar retention rate (ADR) ticked up to 86% after holding at 85% for several quarters. Implied full-year revenue growth has climbed from roughly 60% at the start of the year to about 67% now, and management guided Q4 revenue growth near 52%.
The quality of the quarter deserves scrutiny below the revenue line. The gross loss ratio rose to 65% from 60% in Q2 and 52% in Q4 FY25. Gross profit grew 48% to $118 million, a sharp slowdown from 76% in Q2 and 159% in Q1. Pet makes up roughly 40% of the business, and its loss ratio keeps rising on industry-wide veterinary cost inflation. That problem was flagged last quarter and has now grown large enough to affect guidance. Europe absorbed 29 points of catastrophe and large losses and needs rate action. Operating expenses rose 36%, with G&A up 45% on stock-based compensation and interest expense. The adjusted EBITDA loss of $20 million was essentially unchanged from Q2's $19 million. Management also cautioned that the mix shift toward car could modestly lift the loss ratio, so investors should not count on underwriting margins recovering soon.
The call did preserve a credible growth story, and the catalyst list broadened. Renters is now available in all 50 states, which opens partnerships with distributors that require nationwide coverage. Car launched in Florida, Missouri and Pennsylvania, reaching 14 states that cover more than half the U.S. population. The autonomous-car product is now in six states, where Tesla owners convert at roughly 2.2 times the rate of the broader car product. Management also cited active relationships with automakers beyond Tesla. Cross-sales topped $100 million year to date and are growing about twice as fast as in-force premium, with bundled premium approaching 20%. On costs, headcount slipped to 1,321, and management expects growth spending to rise far more slowly beginning in Q4, the clearest lever for operating leverage. Positive Q4 adjusted EBITDA and a positive full-year 2027 were both reiterated. On the risk side, a shelf registration renewal may revive dilution concerns.
Investors had already turned more cautious before the report. Earnings Whispers sentiment fell from 0.49 at the prior report to 0.15, still positive but a meaningful retreat. Price action was rougher. Shares ran to $56.58 in late August, then slid to a 52-week low of $39.60 on November 3. They rebounded to $45.90 the day before earnings, which is still 6.7% below the open after the July report and about 21% below the 200-day moving average of $57.97. The trend readings are mixed: sequential growth and momentum are positive, while price and AVWAP remain negative. That split mirrors the fundamental divide between accelerating volume and stalled profitability.
Bears have legitimate ammunition. Gross profit growth is decelerating sharply, the net loss widened to $44 million from $38 million, and the revenue raise did not carry through to the profit guide. Bulls can point to a business whose growth has accelerated for three years, a fast-improving distribution footprint, and a spending slowdown that should finally let revenue outrun expenses.
The bottom line is that Lemonade's quarter strengthened the growth case but did little to resolve doubts about profitability. The beat and higher revenue guide are real, but loss-ratio pressure in pet and Europe is now offsetting top-line upside. With shares well below long-term trend and sentiment cooling, the stock likely needs evidence that underwriting margins can stabilize, not just more acceleration in in-force premium.